Human Immunodeficiency Virus (HIV) Antibody Avidity Testing To Identify Recent Infection in Newly Diagnosed HIV Type 1 (HIV-1)-Seropositive Persons Infected with Diverse HIV-1 Subtypes
- 1 February 2007
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 45 (2) , 415-420
- https://doi.org/10.1128/jcm.01879-06
Abstract
A guanidine-based antibody avidity assay for the identification of recently acquired human immunodeficiency virus type 1 (HIV-1) infection was evaluated. The kinetics of maturation of antibody avidity were determined prospectively in 23 persons undergoing acute seroconversion followed for up to 1,075 days. Avidity indices (AI) of ≤0.75 and ≤0.80 reproducibly identified seroconversion within the previous 125 (95% confidence interval [CI], 85 to 164) and 142 (95% CI, 101 to 183) days, respectively. To validate the assay, 432 serum samples from newly diagnosed patients were tested by both the avidity assay and the detuned assay. Results were highly concordant (kappa value for agreement, 0.85). The avidity assay was subsequently used to screen 134 consecutive newly diagnosed patients, including 55/134 (41%) infected with non-B subtypes (A, C, D, G, CRF01, CRF02, CRF06, CRF13, and CRF16). In this cohort, 25/79 (32%) persons with the B subtype and 7/55 (13%) with non-B subtypes showed an AI of ≤0.75, and there were 16/25 (64%) and 3/7 (43%) persons, respectively, with a documented history of acute seroconversion illness within the predicted seroconversion interval. An AI of ≤0.75 was also observed for four patients (three with the B subtype and one with a non-B subtype) who presented with AIDS-defining conditions. In multivariate analysis, an AI of ≤0.75 was associated with younger age, higher HIV-1 plasma RNA load, and being born in the United Kingdom or Ireland rather than in Africa but not with gender, ethnicity, risk group, HIV-1 subtype, or CD4 counts. In conclusion, HIV antibody avidity testing provides a reliable method for identifying recently acquired HIV-1 infection. Results are affected by advanced disease and should therefore be interpreted in the context of other clinical parameters.Keywords
This publication has 23 references indexed in Scilit:
- Comparison of the Avidity Index Method and the Serologic Testing Algorithm for Recent Human Immunodeficiency Virus (HIV) Seroconversion, Two Methods Using a Single Serum Sample for Identification of Recent HIV InfectionsJournal of Clinical Microbiology, 2005
- Diagnoses of HIV-1 and HIV-2 in England, Wales, and Northern Ireland associated with west AfricaSexually Transmitted Infections, 2005
- The changing epidemiology of prevalent diagnosed HIV infections in England, Wales, and Northern Ireland, 1997 to 2003Sexually Transmitted Infections, 2005
- Performance Characteristics of the Immunoglobulin G-Capture BED-Enzyme Immunoassay, an Assay To Detect Recent Human Immunodeficiency Virus Type 1 SeroconversionJournal of Clinical Microbiology, 2004
- Differences in CD4 Cell Counts at Seroconversion and Decline Among 5739 HIV-1–Infected Individuals with Well-Estimated Dates of SeroconversionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
- Evaluation of a Sensitive/Less Sensitive Testing Algorithm Using the bioMérieux Vironostika-LS Assay for Detecting Recent HIV-1 Subtype B' or E Infection in ThailandAIDS Research and Human Retroviruses, 2003
- Precision and Accuracy of a Procedure for Detecting Recent Human Immunodeficiency Virus Infections by Calculating the Antibody Avidity Index by an Automated Immunoassay-Based MethodJournal of Clinical Microbiology, 2002
- Analysis of prevalence of HIV-1 drug resistance in primary infections in the United KingdomBMJ, 2001
- Early Human Immunodeficiency Virus (HIV) Infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: Risk Behaviors, Symptoms, and Early Plasma and Genital Tract Virus LoadThe Journal of Infectious Diseases, 2001
- Clinical Rubella Re-infection During Pergnancy in a Previously Vaccinated WomanJournal of Infection, 2000